Related Articles
Predictive value of Smac, VEGF and Ki-67 in rectal cancer treated with neoadjuvant therapy
Role of MRI‑based radiomics in locally advanced rectal cancer (Review)
Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy
SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma
Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer